Breast cancer screening recall rates: A comprehensive quality analysis

Diagnostic testing for breast cancer is common and recommended for all women and assigned female at birth persons over a certain age and with various risk factors. However, research indicates that mammography and digital breast tomosynthesis recall rates that are too high or too low can have adverse effects.

In this report, we assess breast cancer screening recall rates as measured by CMS and determine ranges for Medicare beneficiaries, commercial beneficiaries, and an aggregate across Medicare and commercial beneficiaries, revealing details like:

• Analysis of states with recall rates above and below the national average
• Regional trends in breast cancer screening recall rates

Download our report to learn how breast cancer screening recall rates vary across markets and payor types.